Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Therapy for Muscle Strength and Mass After Bariatric Surgery
NCT03721497Phase 4Completed
- Sponsor
- Esbjerg Hospital - University Hospital of Southern Denmark
- Start
- Dec 2020
- Primary completion
- Nov 2025
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in male hypogonadism and Sarcopenia comparing Testosterone Undecanoate with Placebo (2 arms). Primary endpoint: Maximal isometric muscle strength in shoulder muscles at week 52. Started Dec 2020; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
male hypogonadismSarcopenia
Beyond the preview
Go deeper on NCT03721497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721497.